FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| STAQ Pharma Inc | 030633271 | 73177-159 | 73177-159-02 | Rocuronium Bromide | 10 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-159 | 73177-159-03 | Rocuronium Bromide | 10 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-109 | 73177-109-26 | Ropivacaine Hydrochloride | 2 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-116 | 73177-116-02 | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-116 | 73177-116-03 | Succinylcholine Chloride | 20 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-114 | 73177-114-15 | Desmopressin Acetate | 1.5 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-123 | 73177-123-02 | Dexmedetomidine Hydrochloride | 4 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-164 | 73177-164-03 | Epinephrine Bitartrate | 10 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-121 | 73177-121-19 | Epinephrine Bitartrate; Tetracaine Hydrochloride; Lidocaine Hydrochloride | .905 mg/1 mL; 5 mg/1 mL; 40 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-163 | 73177-163-33 | Albuterol Sulfate | 5 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-163 | 73177-163-32 | Albuterol Sulfate | 5 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-139 | 73177-139-27 | Fentanyl Citrate | 20 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-05 | Fentanyl Citrate | 50 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-28 | Fentanyl Citrate | 50 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-02 | Fentanyl Citrate | 10 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-01 | Fentanyl Citrate | 10 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-25 | Fentanyl Citrate | 10 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-04 | Fentanyl Citrate | 50 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-16 | Fentanyl Citrate | 50 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-103 | 73177-103-07 | Fentanyl Citrate | 50 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-27 | Fentanyl Citrate | 10 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-03 | Fentanyl Citrate | 10 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-102 | 73177-102-05 | Fentanyl Citrate | 10 ug/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-155 | 73177-155-27 | Ketamine Hydrochloride | 5 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-154 | 73177-154-27 | Ketamine Hydrochloride | 2 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-154 | 73177-154-28 | Ketamine Hydrochloride | 2 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-156 | 73177-156-02 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-156 | 73177-156-27 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-156 | 73177-156-35 | Ketamine Hydrochloride | 10 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-110 | 73177-110-12 | Lidocaine Hydrochloride | 9 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-120 | 73177-120-02 | Lidocaine Hydrochloride | 20 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-118 | 73177-118-03 | Lidocaine Hydrochloride | 10 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-161 | 73177-161-43 | Methadone Hydrochloride | 10 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-149 | 73177-149-02 | Methadone Hydrochloride | 1 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-149 | 73177-149-43 | Methadone Hydrochloride | 1 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-106 | 73177-106-04 | Midazolam | 1 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-106 | 73177-106-05 | Midazolam | 1 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-01 | Morphine Sulfate | 1 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-16 | Morphine Sulfate | 1 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-02 | Morphine Sulfate | 1 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-05 | Morphine Sulfate | 1 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-105 | 73177-105-30 | Morphine Sulfate | 1 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| STAQ Pharma Inc | 030633271 | 73177-122 | 73177-122-01 | Atropine Sulfate | .4 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| Tailstorm Health INC | 118651212 | 81483-0041 | 81483-0041-5 | Bevacizumab | 1.25 mg/.05 mL | 2025-2 | valid | 2026-08-18 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0031 | 81483-0031-0 | Water | 1 mg/1 mL | 2025-2 | valid | 2026-08-18 | |
| TAILSTORM HEALTH INC | 167439715 | 81483-0036 | 81483-0036-0 | Epinephrine Bitartrate; Bupivacaine Hydrochloride | 5 ug/1 mL; 5 mg/1 mL | 2025-2 | valid | 2026-08-18 |